Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Regulatory News (COG)

Share Price Information for Cambridge Cog (COG)

Share Price is delayed by 15 minutes
Get Live Data
37.00    0.00 (0.00%)
Bid:
35.00
Ask:
39.00
Spread: 4.00 (11.429%)
Market Cap: £17.23m
COG Live PriceLast checked at - London Stock Exchange

Intraday Cambridge Cog Share Chart

Total Voting Rights

3 Jul 2023 07:00

RNS Number : 6457E
Cambridge Cognition Holdings PLC
03 July 2023
Β 

3 July 2023

Β 

Cambridge Cognition Holdings plc

Β 

("Cambridge Cognition", the "Company" or the "Group")

Β 

Total Voting Rights

Β 

Β 

Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, announces that pursuant to its block admission facility, details of which were announced on 21 March 2023, it has recently issued 37,444 new ordinary shares in the Company in satisfaction of the exercise of employee share options. Accordingly, as at 30 June 2023 the Company has 34,852,833 ordinary shares in issue.

Β 

There are no shares held in treasury therefore the total number of voting rights in the Company is 34,852,833. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in Cambridge Cognition under the FCA's Disclosure and Transparency Rules.

Β 

The Company intends to notify on a monthly basis when there are changes to the issued share capital of the Company, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company, under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Β 

Enquiries:

Β 

Cambridge Cognition Holdings PlcΒ 

Matthew Stork, Chief Executive OfficerΒ 

Stephen Symonds, Chief Financial OfficerΒ 

Tel: 012 2381 0700Β 

press@camcog.comΒ 

Β 

Panmure Gordon (UK) Limited (NOMAD and Joint Broker)Β 

Freddy Crossley / Emma EarlΒ Β 

Rupert DeardenΒ 

Β 

Tel: 020 7886 2968Β 

(Corporate Finance)Β 

(Corporate Broking)Β 

Dowgate Capital Limited (Joint Broker)Β 

David Poutney / James SerjeantΒ 

Tel: 020 3903 7715Β 

Β 

Β 

IFC Advisory Ltd (Financial PR and IR)Β 

Tim Metcalfe / Graham Herring / Zach CohenΒ 

Β 

Tel: 020 3934 6630Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVRUPUAUMUPWGGG
Date   Source Headline
30th Jun 20207:00 amRNSTrading Update
23rd Jun 20204:18 pmRNSHolding(s) in Company
9th Jun 20207:00 amRNSGrant of Options
5th Jun 20207:00 amRNSCapital Markets Showcase
27th May 20207:00 amRNSOver £1 million of New Contract Wins
6th May 20206:11 pmRNSHolding(s) in Company
6th May 202012:15 pmRNSHolding(s) in Company
5th May 20207:00 amRNSPreliminary Results - Year ended 31 December 2019
29th Apr 20202:19 pmRNSNotice of Results
14th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
23rd Mar 20204:00 pmRNSDelayed Preliminary Results
19th Mar 20207:00 amRNSAward of Innovative Medicines Initiative grant
17th Mar 20207:00 amRNS£1.37 million of new eCOA contracts
10th Mar 20204:15 pmRNSHolding(s) in Company
10th Mar 20204:15 pmRNSHolding(s) in Company
9th Mar 202012:46 pmRNSResult of General Meeting
19th Feb 20207:01 amRNSFundraising to raise £1.4m & Notice of GM
19th Feb 20207:00 amRNSTrading Update and Notice of Results
10th Jan 20203:54 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSCambridge Cognition expands eCOA and wins contract
31st Oct 20194:17 pmRNSGrant of Options
29th Oct 20197:00 amRNSHolding(s) in Company
25th Oct 20197:00 amRNSAlzheimer's drug potential for Cambridge Cognition
26th Sep 201912:15 pmRNSDirector/PDMR Shareholding
23rd Sep 201910:42 amRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSInterim Results
30th Aug 20194:59 pmRNSHolding(s) in Company
29th Aug 20192:20 pmRNSHolding(s) in Company
27th Aug 20197:00 amRNSTrading Update
14th Aug 201910:10 amRNSDr. Nick Kerton
12th Aug 20197:00 amRNSExpansion in Chinese market
22nd Jul 20197:00 amRNSNotice of Results
19th Jul 20197:00 amRNSNew Commercial Partnership for NeuroVocalix
1st Jul 20197:00 amRNSAppointment of Non-Executive Director
11th Jun 20197:00 amRNSCapital Markets Day
23rd May 20192:35 pmRNSResult of AGM and Board Changes
1st May 20197:00 amRNSPosting of Annual Report & Notice of AGM
25th Apr 20197:00 amRNSBoard Changes
17th Apr 20197:00 amRNSGrant of Options
19th Mar 20197:00 amRNS£1.3m digital health contract win
14th Mar 20198:54 amRNSHolding(s) in Company
14th Mar 20197:00 amRNSHolding(s) in Company
12th Mar 20195:23 pmRNSDirector/PDMR Shareholding
12th Mar 201911:59 amRNSHolding(s) in Company
7th Mar 20197:02 amRNSAppointment of Chief Operating Officer
7th Mar 20197:01 amRNSFundraising to raise £2.5 million
7th Mar 20197:00 amRNSPreliminary Results
31st Jan 20197:00 amRNSFirst Partnership in India and New Product Launch
19th Dec 20187:00 amRNSTrading update and notice of results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.